Skip to main content
OpenTrials

Clinical trial condition

Prostatic Neoplasms

Explore clinical trials studying Prostatic Neoplasms. Study availability and eligibility vary by location and protocol.

314 public trials 35 recruiting studies
Refine in advanced search Browse all conditions

Prostatic Neoplasms trial results

Recruiting

A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer

NCT07319871

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +7 more
Locations
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Columbia University Medical Center New York, United States
  • University Hospitals Cleveland Medical Center Cleveland, Ohio, United States
  • The Christie NHS Foundation Trust Christie Hospital Manchester, United Kingdom
View Trial Details
Recruiting

A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer

NCT07082920

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +7 more
Locations
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Columbia University Medical Center New York, United States
  • University Hospitals Cleveland Medical Center Cleveland, Ohio, United States
  • Fred Hutchinson Cancer Center Seattle, Washington, United States
View Trial Details
Recruiting

A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer

NCT06095089

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +7 more
Locations
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
  • Emory University Winship Cancer Institute Atlanta, Georgia, United States
  • University Of Minnesota Minneapolis, Minnesota, United States
  • START New Jersey East Brunswick, New Jersey, United States
View all 16 locations
View Trial Details
Recruiting

A Study of DM002 in Patients With Advanced Solid Tumors

NCT06751329

Conditions
Adnexal Diseases, Colonic Diseases, Colorectal Neoplasms, +33 more
Locations
  • University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States
  • The University of Texas, MD Anderson Cancer Center Houston, Texas, United States
  • Scientia Clinical Research Randwick, New South Wales, Australia
  • Cancer Care Wollongong Wollongong, New South Wales, Australia
View Trial Details
Recruiting

Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20) for Recurrent Prostate Cancer After Surgery.

NCT07483658

Conditions
Biochemical Recurrence of Malignant Neoplasm of Prostate, Digestive System Diseases, Female Urogenital Diseases, +22 more
Locations
  • Gatineau Hospital Gatineau, Quebec, Canada
  • Hôpital Général Juif Montreal, Quebec, Canada
  • McGill University Health Centre Montreal, Quebec, Canada
  • CHU de Québec-Université Laval Québec, Quebec, Canada
View Trial Details
Recruiting

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

NCT06056830

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • University of Alabama Birmingham Hospital Birmingham, Alabama, United States
  • Mayo Clinic- Phoenix Phoenix, Arizona, United States
  • Arkansas Urology Research Center, LLC Little Rock, Arkansas, United States
  • Urology Group of Southern California Los Angeles, California, United States
View all 31 locations
View Trial Details
Recruiting

Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection

NCT05413850

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +12 more
Locations
  • Biogenix Molecular LLC Miami, Florida, United States
  • NovaCure Health Miami, Florida, United States
  • Emory University Hospital Atlanta, Georgia, United States
  • XCancer Omaha / Urology Cancer Center Omaha, Nebraska, United States
View all 21 locations
View Trial Details

Related conditions